» Articles » PMID: 31535189

[Intense Pulsed Light (IPL) As A therapeutic Option for Meibomian Gland Dysfunction]

Overview
Journal Ophthalmologe
Specialty Ophthalmology
Date 2019 Sep 20
PMID 31535189
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Meibomian gland dysfunction (MGD) is a common cause of dry eye disease. Intense pulsed light (IPL) treatment is a new and approved therapeutic option for MGD. The treatment consists of 2-4 sessions where light impulses are applied to the lower lid and temporal lid margin. The IPL technique is a safe form of treatment when the required safety precautions are followed. Current studies document an improvement of patients' subjective symptoms and objectively measured clinical parameters.

Citing Articles

Characterization and Prediction of the Clinical Outcome of Intense Pulsed Light-Based Treatment in Dry Eye Associated to Meibomian Gland Dysfunction.

Iradier M, Del Buey M, Peris-Martinez C, Cedano P, Pinero D J Clin Med. 2021; 10(16).

PMID: 34441869 PMC: 8396809. DOI: 10.3390/jcm10163573.


Combined Low-Level Light Therapy and Intense Pulsed Light Therapy for the Treatment of Dry Eye in Patients with Sjögren's Syndrome.

Di Marino M, Conigliaro P, Aiello F, Valeri C, Giannini C, Mancino R J Ophthalmol. 2021; 2021:2023246.

PMID: 34221491 PMC: 8213457. DOI: 10.1155/2021/2023246.


Intense pulsed light for the treatment of Meibomian gland dysfunction: A systematic review and meta-analysis.

Liu S, Tang S, Dong H, Huang X Exp Ther Med. 2020; 20(2):1815-1821.

PMID: 32765683 PMC: 7388499. DOI: 10.3892/etm.2020.8838.


Use of Intense Pulsed Light to Mitigate Meibomian Gland Dysfunction for Dry Eye Disease.

Suwal A, Hao J, Zhou D, Liu X, Suwal R, Lu C Int J Med Sci. 2020; 17(10):1385-1392.

PMID: 32624695 PMC: 7330664. DOI: 10.7150/ijms.44288.


Therapeutic Effect of Intense Pulsed Light (IPL) Combined with Meibomian Gland Expression (MGX) on Meibomian Gland Dysfunction (MGD).

Wei S, Ren X, Wang Y, Chou Y, Li X J Ophthalmol. 2020; 2020:3684963.

PMID: 32351719 PMC: 7174928. DOI: 10.1155/2020/3684963.

References
1.
Roberts W . Skin type classification systems old and new. Dermatol Clin. 2009; 27(4):529-33, viii. DOI: 10.1016/j.det.2009.08.006. View

2.
Kalangara J, Galor A, Levitt R, Felix E, Alegret R, Sarantopoulos C . Burning Eye Syndrome: Do Neuropathic Pain Mechanisms Underlie Chronic Dry Eye?. Pain Med. 2016; 17(4):746-55. PMC: 6281056. DOI: 10.1093/pm/pnv070. View

3.
de Godoy C, Fernanda da Costa Silva P, de Araujo D, Motta L, Biasotto-Gonzalez D, Politti F . Evaluation of effect of low-level laser therapy on adolescents with temporomandibular disorder: study protocol for a randomized controlled trial. Trials. 2013; 14:229. PMC: 3729421. DOI: 10.1186/1745-6215-14-229. View

4.
Bron A, Tomlinson A, Foulks G, Pepose J, Baudouin C, Geerling G . Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014; 12(2 Suppl):S1-31. DOI: 10.1016/j.jtos.2014.02.002. View

5.
Chung C, Tigges M, Stone R . Peptidergic innervation of the primate meibomian gland. Invest Ophthalmol Vis Sci. 1996; 37(1):238-45. View